Effects of type 2 diabetes mellitus on the pharmacokinetics of berberine in rats

References

• Al-Amer R, Ramjan L, Glew P, Salamonson Y. 2015. Diagnosis of type 2 diabetes: the experience of Jordanian patients with co-existing depression. Issues Ment Health Nurs. 36:231–238.
   PubMed Web of Science ®Google Scholar
• Atkinson MA, Maclaren NK. 1994. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med. 331:1428–1436.
   PubMed Web of Science ®Google Scholar
• Aypak C, Turedi O, Bircan MA, Araz M. 2015. Association of haematological parameters with bone mineral density in elderly diabetic women. Acta Clin Belg. 70:339–344.
   PubMed Web of Science ®Google Scholar
• Chang W, Chen L, Hatch GM. 2015. Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies. Biochem Cell Biol. 93:479–486.
   PubMed Web of Science ®Google Scholar
• Chen G, Lu F, Xu L, Dong H, Yi P, Wang F, Huang Z, Zou X. 2013. The anti-diabetic effects and pharmacokinetic profiles of berberine in mice treated with Jiao-Tai-Wan and its compatibility. Phytomedicine. 20:780–786.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li Y, Wang Y, Yang Q, Dong Y, Weng X, Zhu X, Gong Z, Zhang R. 2015. Comparative pharmacokinetics of active alkaloids after oral administration of Rhizoma Coptidis extract and Wuji Wan formulas in rat using a UPLC-MS/MS method. Eur J Drug Metab Pharmacokinet. 40:67–74.
   PubMed Web of Science ®Google Scholar
• Franch-Nadal J, Roura-Olmeda P, Benito-Badorrey B, Rodriguez-Poncelas A, Coll-de-Tuero G, Mata-Cases M. 2015. Metabolic control and cardiovascular risk factors in type 2 diabetes mellitus patients according to diabetes duration. Fam Pract. 32:27–34.
   PubMed Web of Science ®Google Scholar
• Gong Z, Chen Y, Zhang R, Yang Q, Wang Y, Guo Y, Zhou B, Weng X, Liu X, Li Y, et al. 2015. Pharmacokinetic difference of berberine between normal and chronic visceral hypersensitivity irritable bowel syndrome rats and its mechanism. Arch Pharm Res. 38:1888–1896.
   PubMed Web of Science ®Google Scholar
• Hu FB. 2011. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. 34:1249–1257.
   PubMed Web of Science ®Google Scholar
• Ismail-Beigi F. 2012. Clinical practice. Glycemic management of type 2 diabetes mellitus. N Engl J Med. 366:1319–1327.
   PubMed Web of Science ®Google Scholar
• Jiang SJ, Dong H, Li JB, Xu LJ, Zou X, Wang KF, Lu FE, Yi P. 2015. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats. World J Gastroenterol. 21:7777–7785.
   PubMed Web of Science ®Google Scholar
• Lao-ong T, Chatuphonprasert W, Nemoto N, Jarukamjorn K. 2012. Alteration of hepatic glutathione peroxidase and superoxide dismutase expression in streptozotocin-induced diabetic mice by berberine. Pharm Biol. 50:1007–1012.
   PubMed Web of Science ®Google Scholar
• Lei G, Dan H, Jinhua L, Wei Y, Song G, Li W. 2011. Berberine and itraconazole are not synergistic in vitro against Aspergillus fumigatus isolated from clinical patients. Molecules. 16:9218–9233.
   PubMed Web of Science ®Google Scholar
• Li G, Yang F, Liu M, Su X, Zhao M, Zhao L. 2015. Development and application of a UPLC-MS/MS method for simultaneous determination of fenofibric acid and berberine in rat plasma: application to the drug-drug pharmacokinetic interaction study of fenofibrate combined with berberine after oral administration in rats. Biomed Chromatogr. 30:1075–1082.
   Web of Science ®Google Scholar
• Li H, Liu L, Xie L, Gan D, Jiang X. 2016. Effects of berberine on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism. Pharm Biol. 54:2886–2894.
   PubMed Web of Science ®Google Scholar
• Liu CH, Tang WC, Sia P, Huang CC, Yang PM, Wu MH, Lai IL, Lee KH. 2015. Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance. Int J Med Sci. 12:63–71.
   PubMed Web of Science ®Google Scholar
• Liu L, Liu J, Gao Y, Yu X, Xu G, Huang Y. 2014. Uncoupling protein-2 mediates the protective action of berberine against oxidative stress in rat insulinoma INS-1E cells and in diabetic mouse islets. Br J Pharmacol. 171:3246–3254.
   PubMed Web of Science ®Google Scholar
• Liu M, Su X, Li G, Zhao G, Zhao L. 2015. Validated UPLC-MS/MS method for simultaneous determination of simvastatin, simvastatin hydroxy acid and berberine in rat plasma: application to the drug-drug pharmacokinetic interaction study of simvastatin combined with berberine after oral administration in rats. J Chromatogr B Analyt Technol Biomed Life Sci. 1006:8–15.
   PubMed Web of Science ®Google Scholar
• Liu QF, Shi XJ, Li ZD, Zhong MK, Jiao Z, Wang B. 2014. Pharmacokinetic comparisons of berberine and palmatine in normal and metabolic syndrome rats. J Ethnopharmacol. 151:287–291.
   PubMed Web of Science ®Google Scholar
• Ma BL, Ma YM, Gao CL, Wu JS, Qiu FR, Wang CH, Wang XH. 2011. Lipopolysaccharide increased the acute toxicity of the Rhizoma coptidis extract in mice by increasing the systemic exposure to Rhizoma coptidis alkaloids. J Ethnopharmacol. 138:169–174.
   PubMed Web of Science ®Google Scholar
• Moest H, Frei AP, Bhattacharya I, Geiger M, Wollscheid B, Wolfrum C. 2013. Malfunctioning of adipocytes in obesity is linked to quantitative surfaceome changes. Biochim Biophys Acta. 1831:1208–1216.
   PubMed Web of Science ®Google Scholar
• Oh W, Kim E, Castro MR, Caraballo PJ, Kumar V, Steinbach MS, Simon GJ. 2016. Type 2 diabetes mellitus trajectories and associated risks. Big Data. 4:25–30.
   PubMed Web of Science ®Google Scholar
• Ortiz LM, Lombardi P, Tillhon M, Scovassi AI. 2014. Berberine, an epiphany against cancer. Molecules. 19:12349–12367.
   PubMed Web of Science ®Google Scholar
• Orvos P, Virag L, Talosi L, Hajdu Z, Csupor D, Jedlinszki N, Szel T, Varro A, Hohmann J. 2015. Effects of Chelidonium majus extracts and major alkaloids on hERG potassium channels and on dog cardiac action potential: a safety approach. Fitoterapia. 100:156–165.
   PubMed Web of Science ®Google Scholar
• Park SH, Sung JH, Kim EJ, Chung N. 2015. Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines. Braz J Med Biol Res. 48:111–119.
   PubMed Web of Science ®Google Scholar
• Ren LM, Zhuo YJ, Hao ZS, He HM, Lu HG, Zhao D. 2013. Berberine improves neurogenic contractile response of bladder detrusor muscle in streptozotocin-induced diabetic rats. J Ethnopharmacol. 150:1128–1136.
   PubMed Web of Science ®Google Scholar
• Shankar RR, Xu L, Golm GT, O'Neill EA, Goldstein BJ, Kaufman KD, Engel SS. 2015. A comparison of glycaemic effects of sitagliptin and sulfonylureas in elderly patients with type 2 diabetes mellitus. Int J Clin Pract. 69:626–631.
   PubMed Web of Science ®Google Scholar
• Sun Z, Zhan L, Liang L, Sui H, Zheng L, Sun X, Xie W. 2016. ZiBu PiYin recipe prevents diabetes-associated cognitive decline in rats: possible involvement of ameliorating mitochondrial dysfunction, insulin resistance pathway and histopathological changes. BMC Complement Altern Med. 16:200.
   PubMed Web of Science ®Google Scholar
• Tan KT, Cheah JS. 1990. Pathogenesis of type 1 and type 2 diabetes mellitus. Ann Acad Med Singapore. 19:506–511.
   PubMedGoogle Scholar
• Tangvarasittichai S. 2015. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes. 6:456–480.
   PubMed Web of Science ®Google Scholar
• Wu JS, Liu Y, Shi R, Lu X, Ma YM, Cheng NN. 2014. Effects of combinations of Xiexin decoction constituents on diabetic nephropathy in rats. J Ethnopharmacol. 157:126–133.
   PubMed Web of Science ®Google Scholar
• Zhai L, Gu J, Yang D, Hu W, Wang W, Ye S. 2016. Metformin ameliorates podocyte damage by restoring renal tissue nephrin expression in type 2 diabetic rats. J Diabetes. [Epub ahead of print]. doi: 10.1111/1753-0407.12437.
   PubMed Web of Science ®Google Scholar
• Zhang M, Lv X, Li J, Meng Z, Wang Q, Chang W, Li W, Chen L, Liu Y. 2012. Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis. Mol Cell Endocrinol. 363:122–130.
   PubMed Web of Science ®Google Scholar